Wordt geladen...
Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is neuroprotective not vascular protective
Reperfusion therapy for ischemic stroke can cause secondary brain injury, especially under hyperglycemic (HG) conditions. Here we investigated the effect of acute treatment with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist, prior to postischemic reperfusion, on...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484888/ https://ncbi.nlm.nih.gov/pubmed/23125879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-012-0190-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|